Navigation Links
Medicare Coverage Recommended for In-Home Sleep Testing
Date:1/8/2008

SleepQuest anticipates expanding reach to sleep apnea sufferers

SAN CARLOS, Calif., Jan. 8 /PRNewswire/ -- Millions of men and women who suffer from sleep apnea just got some good news: the agency that regulates Medicare and Medicaid policy recommended the coverage of in-home testing for diagnosis and treatment of sleep apnea.

On December 14, 2007, the Centers for Medicare & Medicaid Services (CMS) released a policy memo proposing to allow coverage of Continuous Positive Airway Pressure (CPAP) based upon diagnosis of sleep apnea by home sleep testing (HST). A public comment period is currently open, and the final policy will be published in March 2008.

The decision follows a September 12 meeting in which physicians and experts on sleep disorders testified before the Medicare Evidence Development & Coverage Advisory Committee (MedCAC) on the merits of at-home testing, including SleepQuest's Chief Scientific Officer, Dr. William C. Dement, the father of modern sleep medicine. SleepQuest is a leading provider of at-home unattended diagnostic sleep testing and sleep apnea treatment, and President Robert Koenigsberg was a vital part of the coalition that fought for approval.

"We worked hand-in-hand with other companies across the country to lobby for this," said Koenigsberg, "and worked closely with physicians who understand the impact that in-home sleep testing can have on a patient's well being."

When the final approval is granted, Medicare sleep apnea patients will no longer be required to undergo sleep testing at more costly and less convenient sleep labs.

"We can do this service anywhere," said Koenigsberg. "Medicare's approval will give us an expanded opportunity to diagnose and treat the effects of sleep apnea and other breathing disorders in the comfortable and effective environment of the patient's own home."

Koenigsberg was also confident other insurance companies would follow suit. CIGNA and Blue Cross already provide coverage for the treatment in some areas.

"Over 10 percent of the US population suffers from sleep related breathing disorders that should be identified and treated," said Koenigsberg. "We've diagnosed thousands of patients with our unique care model in 13 years of business. With increasing demand for in-home sleep testing and sleep apnea treatment, SleepQuest has positioned itself to be ready to meet the needs of newly-covered patients across the country."

For more information visit http://www.sleepquest.com


'/>"/>
SOURCE SleepQuest
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
2. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Imaging Diagnostic Systems Expands Key Patent Coverage
5. Satellites witness lowest Arctic ice coverage in history
6. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
7. Phlo Affiliate Reports Expanded Coverage to Oregon Border
8. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
9. SleepQuest Launches Updated Web Site
10. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
11. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
(Date:3/22/2017)... Florida , March 22, 2017 ... ... various cancer conditions are being pressured as of late due ... for cancer pain management has a dramatic impact on patient,s ... research and development activities for identifying new forms of opioid ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, ... their live events series, “Stem Cell Therapy: The Next Phase in the Evolution of ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help ...
Breaking Biology Technology:
(Date:3/9/2017)... and MOUNTAIN VIEW, Calif. , March ... Made Simple," and 23andMe , the leading personal ... food choices.  Zipongo can now provide customers with personalized ... health goals and biometrics, but also genetic markers impacting ... Zipongo,s personalized food decision support platform uses ...
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
(Date:3/1/2017)... March 1, 2017  Aware, Inc. (NASDAQ: AWRE), a ... Richard P. Moberg has resigned, effective March ... Chief Financial Officer and Treasurer of Aware citing a ... as a member of the Board of Directors of ... co-Chief Executive Officer and co-President, General Counsel has been ...
Breaking Biology News(10 mins):